Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in LXEO — Lexeo Therapeutics, Inc.

CIK 19617 NEW YORK, NY
Back to LXEO Full portfolio

Position in LXEO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$448,229
-$86,525 QoQ
Shares Held
96,290
+3.4% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 141 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 65% Shared 0% None 35%

Common Shares in LXEO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,254,031 across 424 Biotechnology names. LXEO ranks #204 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in LXEO

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $448,229 96,290
2026-03-31 $534,754 93,163
2025-12-31 $296,519 29,861
2025-09-30 $95,343 14,359
2025-06-30 $55,274 13,750
2025-03-31 $47,815 13,780
2024-12-31 $87,980 13,371
2024-09-30 $92,912 10,278
2024-06-30 $69,982 4,363
2024-03-31 $93,342 5,953
2023-12-31 $1,503 112